Ticagrelor alone versus ticagrelor plus aspirin from month 1 to month 12 after percutaneous coronary intervention in patients with acute coronary syndromes (ULTIMATE-DAPT): a randomised, placebo-controlled, double-blind clinical trial

Post time 2024-4-23 16:10:01

Ticagrelor alone versus ticagrelor plus aspirin from month 1 to month 12 after percutaneous coronary intervention in patients with acute coronary syndromes (ULTIMATE-DAPT): a randomised, placebo-controlled, double-blind clinical trialZhen Ge 1, Jing Kan 1, Xiaofei Gao 1, Afsar Raza 2, Jun-Jie Zhang 1, Bilal S Mohydin 3, Fentang Gao 4, Yibing Shao 5, Yan Wang 6, Hesong Zeng 7, Feng Li 8, Hamid Sharif Khan 9, Naeem Mengal 10, Hongliang Cong 11, Mingliang Wang 12, Lianglong Chen 13, Yongyue Wei 14, Feng Chen 15, Gregg W Stone 16, Shao-Liang Chen 17; ULTIMATE-DAPT investigators

Collaborators, Affiliations expand

PMID: 38599220

Post time 2024-4-23 16:10:02

: This post has been completed
Completed attachments will be deleted within 24 hours.

[Other] Ticagrelor alone versus ticagrelor plus aspirin from month 1 to month 12 after percutaneous coronary intervention in patients with acute coronary syndromes (ULTIMATE-DAPT): a randomised, placebo-controlled, double-blind clinical trial